PharmiWeb.com - Global Pharma News & Resources

Company Directory - Pharmaco

A leading global biotech company that strives to develop and deliver innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions live full lives.
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).
We are a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in disorders of the complement and coagulation systems. Proteases are the natural regulators of these biological systems.
At Celgene, we appreciate the unique qualities our employees bring. Creative. Inventive. Passionate. Driven. It’s the compilation of all these things that make us who we are as a company. That’s why we believe in empowering every individual.
Centessa represents a new kind of pharmaceutical company that operates in a bottom-up organizational structure with a deconstructed R&D environment that prioritizes data driven decision making led by subject matter experts.
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts
Chugai Pharma Europe has been bringing novel therapies to patients in Europe since 1993. Headquartered in London, we employ over 250 highly skilled experts, with offices in the UK, Germany and France.
Clinigen (Clinigen Group) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines to improve the quality of people's lives around the world.
Clinion is a life sciences technology company offering innovative software solutions in the pharmaceutical industry since 2010.
Commercial Eyes is the foremost life sciences commercialisation business in Australia and New Zealand. For nearly 20 years we have supported the needs of more than 650 pharmaceutical, medical device, diagnostic and consumer healthcare companies.
Established in 2005, we are a medium sized pharmaceutical company with a rich heritage of commercialising products in complex markets and in therapeutic areas such as women’s health, urology and endocrinology.
Covis, with global operations in Zug, Switzerland, is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses.
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents.
Croma-Pharma GmbH is an Austrian family company based in Leobendorf in the north of Vienna. The company specializes in the industrial production of hyaluronic acid syringes and is one of the world's leading experts in this field.
At Cromos™ Pharma our philosophy is simple – our patients and clients come first. We strive to assist our partners in advancement of their clinical development programs that improve the lives of our patients. Since our establishment in 2004, we have fine-tuned our business model to reflect validated best practices from the most highly regulated venues, which we have carefully tailored to suit local environments.
We are dedicated to fundamentally changing the mental healthcare experience for those affected by mental illness, and their loved ones, through delivering powerful and effective new psychedelic-based therapies that are accessible to all.
Building on our heritage in pharmaceutical grade lactose, DFE Pharma provides a wide range of excipient products and services for oral solid dose and dry powder inhalation formulations, and we do it on a global basis. We live up to our values to deliver the best, today, tomorrow, always.
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important emerging cancer treatments.